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Abstract 
Background: The rapid and continuous growth of health care cost aggravates the frequently low priority and less 
attention given in financing laboratory services. The poorest countries have the highest out-of-pocket spending as a 
percentage of income. Higher charges might provide a greater potential for revenue. If fees raise quality sufficiently, 
it can enhance usage. Therefore, estimating the revenue generated from laboratory services could help in capacity 
building and improved quality service provision.
Methods: Panel study design was used to determine revenue generated from clinical chemistry and hematology 
services at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia. Activity-Based Costing (ABC) model 
was used to determine the true cost of tests performed from October 2011 to December 2011 in the hospital. The 
principle of Activity-based Costing is that activities consume resources and activities consumed by services which 
incur the costs and hence service takes the cost of resources. All resources with costs are aggregated with the 
established casual relationships. The process maps designed was restructured in consultation with the senior staffs 
working and/or supervising the laboratory and pretested checklists were used for observation. Moreover, office docu-
ments, receipts and service bills were used while collecting data. The amount of revenue collected from services was 
compared with the cost of each subsequent test and the profitability or return on investment (ROI) of services was 
calculated. Data were collected, entered, cleaned, and analyzed using Microsoft Excel 2007 software program and 
Statistical Software Package for Social Sciences version 19 (SPSS). Paired sample t test was used to compare the price 
and cost of each test. P-value less than 0.05 were considered as statistically significant.
Result: A total of 25,654 specimens were analyzed during 3 months of regular working hours. The total numbers of 
clinical chemistry and hematology tests performed during the study period were 45,959 (66.1 %) and 23,570 (33.9 %), 
respectively. Only 274, 386 (25.3 %) Ethiopian Birr (ETB) was recovered from the total cost of 1,086,008.09 ETB incurred 
on clinical chemistry and hematology laboratory tests. The result showed that, about 133,821 (12.32 %) ETB was rev-
enue not collected from out-of-pocket payments that was paid for the services as a result of under pricing. The result 
showed that 18 out of 20 laboratory tests were under priced. The cost burden related to free Anti Retro-viral Therapy 
(ART) services was 285,979.82 (26.3 %) ETB.
Conclusion: The cost per test estimated was significantly different to the existing price. About 90 % of the tests were 
under priced. This information could warn the hospital to reconsider resetting prices of these tests profitability ration 
less than 1. The revenue collected could help to build capacity, upscale quality, and sustainable service delivery.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background
Health laboratories are integral and essential compo-
nent of health system [1–3]. They provide vital support; 
facilitate the initiation and monitoring of appropriate 
clinical and public health interventions [1]. Laboratory 
results provide invaluable tools for making decisions and 
improving the wellbeing of the patients’ [3, 4]. Despite 
this central role laboratory services have, strengthening 
it until recently received little or inadequate attention in 
many developing countries [1, 3].
In addition to this, the continuing and rapid growth 
of health care costs strain budget [5]. The cost of health 
care is not the only barrier to health care access; there is 
a wide range of affordability, availability and acceptability 
barriers severely affecting the most poorer groups [6].
These poorest people have the highest out-of-pocket 
(OOP) spending as a percentage of their income [7]. 
Changing the financing mechanisms from OOP payment 
towards a greater reliance of prepayment mechanisms 
is necessary to address the full range of access barriers 
[6]. Payment presents barrier to health care service uti-
lization and accessing the basic quality health care ser-
vice utilization which is still denied to many poor people 
of the world [6, 8]. OOP payments are not equitable in 
chain and have the effect of excluding the poor from 
health care access as they cannot afford to pay for medi-
cal care and withdraw from treatment [9]. As the result of 
payments, poor households are likely to sink even further 
into poverty because of the adverse effects of illness on 
their earnings and general welfare [10].
Healthcare reform in the financing strategies include 
revising user fee and retaining the collected money at the 
public health facilities [11]. Higher charges might pro-
vide a greater potential for revenue [12]. User fee is an 
important source of revenue for public health care facili-
ties [13]. This important resource enable the health care 
providers to render quality health care services, ration-
alizing, and designing rules for fee waivers [13]. Rev-
enue empowers the facilities to provide quality service, 
increase patient satisfaction, and determines ones will-
ingness to pay [14]. The more the people are willing to 
pay the better is the chance health care facilities to pro-
vide quality services [14]. If fees raise quality sufficiently, 
it can enhance usage [4].
Efficiency is possible through improving outcome and/
or reducing cost. Cost factors contributing for the cost 
of services was used to redesign the process and esti-
mate the amount of revenue that could be increased as 
the result of reduced cost of rendering services [15]. Cost 
information has paramount importance for providing 
services at reasonable price and estimate the amount of 
revenue collected from patients. Firms use accurate cost 
of services for determining profitability and make long-
term strategic and day-to-day operating decisions [13]. 
Nowadays, with the growth and development of advance-
ment and changes in technology and effects on costs are 
very significant [16]. Therefore; it is vital to estimate rev-
enue that could be collected from laboratory services and 
evaluate the profitability for the particular services for 
thinking and planning of better quality service [8]. The 
revenue collected in the hospitals could serve for plan-
ning for better quality services that are provided at gov-
ernment hospital.
Methods
Tikur Anbesa Specialized Teaching Hospital is found in 
the center of Addis Ababa, the capital city of Ethiopia. 
The hospital has an area of 123,000  m2 and its building 
rests on an area of 45,000 m2 of land. It was reported that 
its construction cost of the building with some advanced 
medical equipments 21,605,399.00 ETB at the time of 
its inauguration on 3rd November 1973. There are 1262 
various rooms from the basement to the eighth floor of 
the building. It has been undertaking medical services, 
providing training in the medical profession at different 
levels and conducting research activities in the fields of 
medicine and other sciences since 1974 [17]. The hospi-
tal is the highest referral hospital of the country and has 
been doing researches, teaching various disciples of stu-
dents, and providing various degrees of specialized com-
munity services since its inauguration.
Panel study was designed to estimate the cost of render-
ing diagnostic laboratory testing services and to calculate 
the actual revenues collected from clinical chemistry and 
hematology laboratory services. In addition to this, the 
payment status of each request with all the service com-
plex or compositions were observed along with the types 
of tests performed while grabbing data on all resources 
consumed during the process of diagnosis. The amount 
of revenue collected per test from service charge was 
estimated for each test. The laboratory test service charge 
or price was used for estimating the revenue generated 
from each tests and patient’s payment status was used 
while collecting data for revenue estimation. The service 
prices were fixed for each test. The service revenue col-
lected from each laboratory test was estimated from the 
service bills, and/or patient receipts. ABC tool was used 
to assess the correct cost of services.
Keywords: Revenue, Cost, Activity-based costing, Laboratory service, TASTH
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All resources consumed with activities were traced 
and/or allocated for costing laboratory services. All clini-
cal chemistry and hematology laboratory examination 
sub processes or process maps were designed. While 
designing or analysis and designing of process maps 
work breakdown structures which could trap all resource 
inputs, the authors used direct observation using pre-
tested data collection checklists, instrument user man-
uals, reagent insert kits, laboratory bench aids, and 
standard operating procedures.
Steps in estimating laboratory service revenue and 
profitability.
First: identify procedures of interest (tests of clinical 
chemistry and hematology).
Second: determine work breakdown structure or pro-
cess maps.
Third: determine all the resources associated to the 
testing processes.
Fourth: establish cause/effect relationships with 
resources, activities and services.
Six: collect the cost of services from activities and 
aggregate to the cost object.
Seven: calculate the revenue from the services.
Eight: compare the revenue and cost and determine the 
profitability of each test.
The historical cost and/or market prices of resources 
were collected form service bills, cost information or 
receipts. Data was collected from different department 
like purchasing, finance, property, marketing, clinical 
departments and other support departments. The cost 
and/or price information was collected from different 
departments of the hospital be it either from cost centers 
or revenue centers. We used flexible method of data col-
lection. Payroll, service bills, models, office documents, 
agreement contracts were used both from the hospital 
and outside the hospital stakeholders supplying different 
reagents and materials as fixed asset or inventories. The 
service bills of water, electricity, telephone, and others 
were used as data. The depreciation cost of fixed assets 
was calculated using single line depreciation method. The 
cost of resources were assigned or allocated to the service 
based on the amount of services provided or resources 
consumed to the laboratory activities.
Resources used at various stages of the activities were 
observed and coded for easier data collection, entry and 
analysis. The cost of each of the resources was associ-
ated based on the amount of service or the cost of the 
resources consumed according to the relationships estab-
lished by using the innovative costing model. Data were 
entered into Microsoft (MS) Excel 2007 spreadsheet pro-
gram and analysis was performed using MS Excel 2007 
spread sheet and SPSS (version 19.0, Chicago, IL, USA) 
programs. Cost versus price was compared using paired 
sample t-test. P ≤ 0.05 was used as a cut-off for consider-
ing statistical significance of the tests.
The study was conducted after formal approval let-
ter obtained from the Department Research Ethics 
and Review Committee (DRERC) of the department of 
Medical Laboratory Sciences, School of Allied Health 
Sciences, College of Health Sciences, Addis Ababa Uni-
versity. An official letter was communicated to Tikur 
Anbesa Specialized Teaching Hospital. Institutional 
based formal approved letters were obtained from the 
hospital and then communicated to all conceivable 
departments.
Result and discussion
The health care financing reform of Ethiopia states about 
the retention, utilization of revenues, and administration 
of fee waiver system and establishment of facility gov-
ernance bodies. According to 2008/2009 performance 
report, there were 73 hospitals and 823 health centers 
have already started retaining revenues [18]. The strate-
gies of the reform include revising user fees charged at 
government health care facilities. Price revision requires 
accurate cost information. The detailed research esti-
mated correct cost information on which cost has to 
rely on. Basing on the cost information, citizens in gov-
ernment health facilities payment mechanisms were 
devised. These mechanisms depend on the type of ser-
vices, whether the consumer have waiver certificate for 
non-exempted services. According to Healthcare Financ-
ing Reform Implementation Manual of 2010, government 
health facilities had been collecting very little revenue 
from user fees in comparison to the allocated budget 
from government treasury [11]. The revenue collected at 
hospital could serve to provide additional capacity to ful-
fill resources and hence to up scale the quality of services 
rendered to the patients. TASH could use this opportu-
nity to improve the quality of service by building internal 
staff capacity through training providing resources.
During the study period a total of 25,654 specimens 
were collected and received for analysis. The total num-
bers of clinical chemistry and hematology tests per-
formed during the study period were 45,959 (66.1  %) 
and 23,570 (33.9  %), respectively. Among these 15,028 
(58.6  %) of them were hematology specimens and the 
remaining were clinical chemistry specimens. Among 
all specimens sent for analysis, 12,793 (49.87 %), 12,636 
(49.26  %) and 228 (0.88  %) of specimens were with the 
payment status of free, paid and with unknown payment 
status, respectively. This indicates that nearly half of the 
total specimens are free laboratory service beneficiaries. 
From which clinical chemistry specimens account about 
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5556 (52 %), 4842 (46 %) and 228 (2 %) of free, paid and 
unknown payment status, respectively. Similarly, from 
7794 (52 %) hematology specimens revenue was collected 
but from remaining not. This differs to the findings of 
the research done in Gondar from secondary data where 
46,178 (17.7  %) of the patients were free health service 
beneficiaries. The reason for difference could be due to 
the difference in methodology, time, socio-economic 
status [19]. On the other hand, the result of facility exit 
survey conducted in Jimma, southwest reported about 
58 % of the respondents were free health care beneficiar-
ies [20]. The gap among these three studies may be due 
to the absence of clearly stated criteria for recruiting and 
providing waive certificate as it is suggest by the two pre-
vious studies [19, 20] and failure to serve the disadvan-
taged and vulnerable groups. There might be missing of 
the vulnerable and including those who do not deserve. 
However; currently criteria is set to which group of soci-
ety waiver certificate is to be given. The general problem 
regarding the implementation of free certificate provision 
for the needy might be the case for the differences among 
studies. The problem might continue on the practice of 
providing to the real poor who deserves free services at 
public health facilities. The screening systems justify-
ing the real evidence of poverty should be balanced and 
well addressed and those who provide waived certificate 
should take the responsibility on behalf of free health 
care beneficiaries.
Financial protection from all forms of costs of health-
care and enabling access to all citizens are key elements 
for universal health coverage. However, relatively limited 
progress towards universal coverage has been made in 
African countries [21]. The experience of Guinea, Nigeria 
and Cameroon showed that 70 % or more was financed 
through out-of pocket payment which is more than 
the result of our study. On the contrary, it is more than 
the experience of Ghana and Rwanda ensured univer-
sal health coverage and sustainable financial protection 
through domestic pre-payment financing [21]. The dif-
ference that occurred among these countries may be due 
to the socioeconomic differences, study setting and dif-
ferences in the government policy differences. It may also 
be due to the setting where the research was done. The 
experience of the mentioned Africa countries is gross and 
our report is research output done in one referral hospital 
where the service mix is quite different from the overall 
picture of the country wide health system. Our countries 
perhaps use either one or a combination of both financ-
ing mechanisms and still other better mechanisms may 
be devised. The health care financing mechanism(s) 
should be implemented as far as it does not affect the 
health care seeking behavior of the citizens. These might 
be due to financing mechanisms and the socioeconomic 
difference of the countries. It differs to a study conducted 
in Indian in 2010 where only 10  % of patients got free 
laboratory and diagnostic services. Another 50  % were 
offered subsidized rates or a lower affordable price while 
remaining 40 % were charged in the private category [22]. 
The difference might be due to policy difference and soci-
oeconomic of two countries. The hospital could use the 
experience of India to collect more revenue after request-
ing the change in the policy issues.
The total cost of clinical chemistry and hematol-
ogy laboratory services was about 1,008.09 ETB. From 
this amount of health care the hospital expended, only 
274,386 (25.3  %) ETB was collected from patients dur-
ing the study period. This revenue is lower than 37 % of 
money which is managed by household out-of-pocket 
payments as of the 2007/08 National Health Expendi-
ture [21]. This may be due to under pricing. The total cost 
of tests from HIV positive individuals was 285,979.82 
(26.3 %) ETB. All of them were exempted for laboratory 
test services. According to the result of our study 140,849 
(37.1  %) ETB was collected from the total known cost 
of 380,963.63 (97.9 %) ETB paid and free served clinical 
chemistry tests is depicted in (Table 1) and 7934 (2.1 %) 
ETB costs of the tests were with unknown payment sta-
tus which is not displayed in (Table 1). This is the main 
reason for the very low amount of revenue collected 
from OOP payments is due low 0.88 average profitabil-
ity ratio (PR) or return on investments (ROI). In addi-
tion to this service were under priced (see Table  1) for 
PR or ROI or price. The revenue from clinical chemistry 
paid services was less with an amount 19,846.41 (5.2 %) 
ETB. From a total cost of Br. 648,935.8 (100.00  %) for 
hematology tests only 133,537 (19.16  %) ETB revenue 
was collected through user fee OOP payments. This was 
less than 113,974.20 (17.6  %) ETB that could have been 
collected with PR equal to 1 which is in fact less than an 
ideal cost for non profitable public service price setting, 
though there is a need to mark up price is necessary. The 
internal comparison for clinical chemistry and hematol-
ogy showed better performance for clinical chemistry 
service profitability. This amount of money is part of the 
hospital unused capacity. Relatively lower gross amount 
of revenue loss from clinical chemistry tests might be due 
to marked up pricing of LDL-C and TG tests. Had price 
been set on the cost of services 37.6 % of the service cost 
would have been recollected. This would have been simi-
lar to 2007/08 NHE 37 % which was reported to managed 
and financed through OOP payment [21].
The result of our study showed that the profitability 
ratio (PR) of 18 from 20 tests did not reach 1. On the 
other hand, in Thai study only 6 out of 53 did not reach 
PR 1. The average PR of our study was 0.75 while in Thai 
study it was 4.46. The actual PR in our study was 0.26 in 
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contrasts to this it was 3.3 in Thai study, which was cal-
culated when the actual revenue divided to the actual 
cost was. PR was 0.88 for clinical chemistry and 0.39 for 
hematology tests (Table 1).
The possible reason for intra study and the inter study 
PR difference may be due to the policy and the pricing 
inefficiency [23]. There was a statistically significant dif-
ference between cost and price for all tests with P-value 
<0.001 for all tests (Table  2). Only two from twenty 
tests were priced with some mark up but the remain-
ing test profiles were under priced. The numbers of 
tests performed per day were significantly different with 
(P < 0.001). This may be due to the schedule of the hos-
pital’s departments and stock out of reagent and machine 
down time.
It is much great surprising to report or say 18 out of 20 
services were under priced and did not reach with profit-
ability ratio 1. The same could happen to any other ser-
vices delivered to the patients by TASH and even other 
health institutions of the country. The government could 
give emphasis to plan such huge capacity that could help 
to scale up the quality of services. In general there is big 
gap between the cost and the price set for services ren-
dered in exchange for laboratory services. The hospital 
should give much attention to costing even any other 
services provided in the hospital. The revenue generated 
could help to hospital to plan for more improved quality 
services by using unused capacity which is an important 
resource or good opportunity for hospitals to think about 
better quality services at all settings.
Conclusion
The total revenue collected from services provided dur-
ing the study period was 274,386 (25.3 %) ETB. The total 
cost of services of clinical chemistry and hematology was 
1,086,008.09 ETB. About 133,821 (12.32 %) ETB was not 
collected as a result of under pricing (Table 1). The ART 
service burden was about 285,979.82 (26.3 %) ETB. The 
cost per test was significantly different from the price 
charge for all laboratory services provided in the hospital. 
Only two tests from 20 were priced with some mark up, 
but the remaining 18 test profiles were under priced and 
Table 1 The total cost, and  profitability to  prices charged on  tests at TASH, Addis Ababa, Ethiopia, October–December 
2011
ABO blood group; BM blood morphology; CBC complete blood count; CHO cholesterol; CI confidence interval; Cr creatinine; CD4+ CD4+ test; ESR erythrocyte 
sedimentation rate; FBS fasting blood sugar; PCV packed cell volume; df degree of differentiation; AST aspartate transaminase; ALT alaninine transaminase; ALP 
alkaline phosphatase; TG triglyceride; HDL-C high density lipoprotein cholesterol; LDL low density lipoprotein; RBS random blood sugar; STP serum total protein; CSFP 
cerebrospinal fluid total protein; Hemat hematology
Test profile Free Paid Total PR
Cost Price Price Cost Cost Price
Cr 31,956 28,315 29,555 26,188 62,861 55,700 0.89
Urea 33,136 28,287 30,644 26,160 65,191 55,651 0.85
AST 25,582 22,218 22,384 19,440 49,046 42,596 0.87
ALT 25,502 22,176 22,308 19,398 48,889 42,512 0.87
ALP 25,229 21,938 22,034 19,160 48,349 42,043 0.87
CHO 11,660 9905 4029 3423 15,977 13,573 0.85
FBS 22,917 20,027 11,615 10,150 35,060 30,639 0.87
LDL 4069 6100 1641 2460 5776 8660 1.5
Tg 10,868 20,175 3701 6870 14,835 27,540 1.86
HDL-C 25,978 13,370 8880 4570 35,499 18,270 0.51
STP 3111 2424 3604 2808 6853 5340 0.78
CSFP 262 192 303 222 573 420 0.73
Clin. che. total 220170 195127 160698 140849 388909 342944 0.88
CBC 192967 104705 196411 106483 389378 211188 0.54
PCV 4539 1576 9919 3444 14458 5020 0.35
ESR 12134 7030 15586 9030 27720 16060 0.58
ABO 10302 6060 20135 11844 30437 17904 0.59
BM 1454 700 2416 1155 3870 1855 0.48
Malaria 1747 845 1634 790 3381 1635 0.48
CD4 + 177282 0 0 0 177282 0 0
RBS 999 560 1411 791 2411 1351 0.56
Hemat total 401425 121476 247511 133537 648936 255013 0.39
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the average profitability of clinical chemistry was 0.88 
and that of hematology tests was 0.39. The overall rev-
enue collected from clinical chemistry and hematology 
laboratory services was about a quarter of the total cost 
incurred for rendering service during the study period. 
The government could use this result so as to think of 
more researches and take timely action so as to revise 
user fees at public health institutions and use the money 
generated for planning more improved service provision. 
Nearly half of the patients are free certificate user. There-
fore; the hospital, the government and any stakeholders 
involved in providing waived certificate could take time 
to think and revise user certificate provision systems and 
make it more clear, transparent, economical to identify 
those who deserve and enable them access the certifi-
cate effectively so as to increase the universal health care 
service coverage. The revenue could help the hospital to 
build up the capacity for more efficient, improved quality 
health care services. ABC tool could be used for correct 
cost estimation, revenue estimation of profitability analy-
sis, efficient resource allocation, and improved quality 
service provision. There is a great gap between and the 
cost of laboratory services and price set for them. Hence, 
the hospital should adapt better costing methods rather 
than going simply with traditional methods of costing. 
For this the authors would like to suggest the best costing 
model ABC while implementing costing strategies.
Strength and limitation of the study
The strength of our study was a detailed cost analysis of 
the laboratory services using ABC and large sample size. 
The limitation of this study is that the involvement of 
internship students in the activities the diagnostic ser-
vices was not considered. We did not also consider the 
fixed assets used for more than useful life years.
Table 2 Cost versus price difference of tests comparison of clinical chemistry and hematology tests performed at TASH, 
Addis Ababa, Ethiopia, Oct. 2011 to Dec. 2011
ABO blood group; BM blood morphology; CBC complete blood count; CHO cholesterol; CI confidence interval; Cr creatinine; CD4+ CD4+ test; ESR erythrocyte 
sedimentation rate; FBS fasting blood sugar; PCV packed cell volume; df degree of differentiation; AST aspartate transaminase; ALT alaninine transaminase; ALP 
alkaline phosphatase; TG triglyceride; HDL-C high density lipoprotein cholesterol; LDL low density lipoprotein; RBS random blood sugar; STP serum total protein; CSFP 
cerebrospinal fluid total protein; Hemat hematology
Paired samples test
Paired differences Sig.(2-tailed)
Mean (95 % CI of difference) SD SE of mean t df p-value
Clinical chemistry
 Cr 0.674 (0.667–0.068) 0.39 0.004 177.952 10625 0.000
 Urea 0.898 (0.888–0.908) 0.521 0.005 177.641 10625 0.000
 AST 0.607 (0.597–0.617) 0.524 0.005 119.314 10625 0.000
 ALT 0.600 (0.590–0.610) 0.520 0.005 119.039 10625 0.000
 ALP 0.593 (0.584–0.603) 0.521 0.005 117.519 10625 0.000
 CHO 0.226 (0.217–0.235) 0.479 0.005 48.698 10625 0.000
 FBS 0.416 (0.407–0.425) 0.497 0.005 86.268 10625 0.000
 LDL −0.271 (−0.289 to −0.254) 0.911 0.009 −30.704 10625 0.000
 Tg −1.196 (−1.245 to −1.246) 2.616 0.025 −47.109 10625 0.000
 HDL-C 1.625 (1.554–1.689) 3.558 0.035 46.970 10625 0.000
 STP 0.142 (0.133–0.151) 0.471 0.005 31.165 10625 0.000
 CSFP 0.014 (0.011–0.017) 0.171 0.002 8.394 10625 0.000
Hematology
 CBC 11.85 (11.78–12.92) 3.76 0.03 393.569 15027 .000
 PCV 0.63 (0.59–0.66) 2.08 0.02 37.003 15027 .000
 ESR 0.78 (0.75–0.80) 1.49 0.01 63.911 15027 .000
 ABO 0.83 (0.81–0.86) 1.68 0.01 61.014 15027 .000
 Malaria 0.12 (0.10–0.13) 0.78 0.01 18.283 15027 .000
 CD4+ 11.79 (11.22–12.37) 35.82 0.29 40.364 15027 .000
 BM 0.13 (0.12–0.15) 0.85 0.01 19.404 15027 .000
 RBS 0.07 (0.06–0.08) 0.62 0.01 13.982 15027 .000
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